Loading

Journal of Veterinary Medicine and Research

The Salmonella or Micro Some Micro Suspension Assay and Genetic Polymorphism Analysis in a Case-Report of Air Pollution in Rio De Janeiro, Brazil

Case Report | Open Access

  • 1. Departamento de Biofísica e Biometria, Universidade do Estado do Rio de Janeiro, Brazil
  • 2. Departamento de Genética e Biologia Molecular, Universidade do Federal do Estado do Rio de Janeiro, Brazil
+ Show More - Show Less
Corresponding Authors
Israel Felzenszwalb, Departamento de Biofísica e Biometria, Universidade do Estado do Rio de Janeiro, Av. 28 de setembro 87 fds 4º. Andar, 20551-030, Rio de Janeiro, Brazil, USA
Abstract

The use of strains of Salmonella enteric serovar Typhimurium with different metabolic capacities can indicate the class or classes of compounds present in an environmental sample and enable the diagnosis of the mutagenic activity of these pollutants adsorbed on particulate matter (PM) in the air. The sensitivity of Salmonella strains TA98NR, TA98/1, 8-DNP6, YG1021, and YG1024 to detect nitro compounds adsorbed on samples of PM 2.5 was compared from three sites in Rio de Janeiro city. Samples were collected using a high-volume sampler at three sites: one with light traffic and two with heavy traffic. The assays were performed in the presence of 10-50 μg/plate organic extracts with and without exogenous metabolization. The YG1021 and YG1024 strains showed the highest rev/m3 values, confirming their enhanced sensitivity. As YG1024 also demonstrated sensitivity to nitro and amino compounds, we suggest its use in research into environmental air contamination. Individual susceptibility to chemically induced cancer may be partly explained by genetic differences in the activation and detoxification of procarcinogens. Numerous polymorphisms of metabolism genes have been identified and their role in individual susceptibility to cancer has been observed. We evaluated genetic polymorphisms and risk of lung cancer in Rebouças tunnel workers (Rio de Janeiro – Brazil). Deletions of GSTM1 and GSTT1 genes were detected in 100% of samples from control group. In exposure group, single deletions of GSTM1 or GSTT1 genes were detected in 72.74% (n=1) to 86.37% (n=13), respectively. Deletions of both genes were detected in 100% (n = 15). The same individual showed CYP1A1*2B polymorphism and deletions of GSTM1 and GSTT1 gens. These results demonstrate that this individual exposed to occupational pollution at Rebouças tunnel, may have intensified metabolizing pollutants such as PAH, and have difficulties in detoxification of metabolites of these pollutants, increasing the risk of lung cancer development.

Keywords


•    Salmonella enteric serovar typhimurium
•    Nitroarenes
•    Mutagenicity
•    Polymorphisms
•    Lung cance

Citation

Rainho CR, Moraes É, Aiub CAF, Mencalha AL, Felzenszwalb I (2016) The Salmonella/Micro Some Micro Suspension Assay and Genetic Polymorphism Analysis in a Case-Report of Air Pollution in Rio De Janeiro, Brazil. J Vet Med Res 3(5): 1063.

INTRODUCTION

The Salmonella/micro some micro suspension assay has been used for large, multisite, and/or time series studies, for bioassay-directed fractionation studies, for identifying the presence of specific classes of mutagens, and for site or source comparisons of relative levels of airborne mutagens [1]. The use of strains of Salmonella enteric serovar Typhimurium with different metabolic capacities can indicate the class or classes of compounds present in an environmental sample [2,3]. The Salmonella/microsome assay identifies the presence of organic compounds and enables diagnosis of the mutagenic activity of these pollutants adsorbed on particulate matter (PM) in the air. The responses are related to the presence of a variety of compounds, including polycyclic aromatic hydrocarbons (PAHs) and nitroarenes [4,5]. Nitroarenes are a class of environmentally hazardous compounds [6]. These nitro compounds have been detected in the extracts of diesel and gasoline emissions, fly ash, cigarette smoke condensates, and home heater emissions [7,6]. Typical nitroarenes, such as 2-nitrofluorene, 1-nitropyrene (1- NP), and 1, 8-dinitropyrene (1, 8-DNP), are potent mutagens [8,6]. The contributions of nitroarenes to direct mutagenic activity are commonly investigated through the Salmonella/microsome assay with the following S. enteric serovar Typhimurium strains: TA98 (frame shift strain) and the derivative strains TA98/1.8- DNP6 (O-acetyl transferase-deficient), TA98NR (nitroreductasedeficient) [9], YG1021 (nitroreductase-overproducing), and YG1024 (O-acetyltransferase-overproducing) [10]. Genotoxic evaluation studies of particulate matter using these strains have been conducted previously [11,12,5,3,13-17]. Many studies have shown that variant CYP1A1 alleles combined with GSTM1 and GSTT1 nulls genotype are associated with an increased risk of lung cancer [18-21]. Damage to the genetic material and high concentrations of PAH metabolites were detected in biological samples taken from Rebouças tunnel workers and can be related to daily exposure to pollutants in the tunnel [22].

CASE PRESENTATION

In the present study, comparisons were made of the sensitivity of strains of Salmonella enteric serovar Typhimurium to detect nitro compounds adsorbed on samples of PM 2.5 collected at three sites in the city of Rio de Janeiro: site 1, State University of Rio de Janeiro Capus with light traffic, is located in a residential area of the city northern zone; site 2, Brazil Avenue has heavy traffic (~250,000 vehicles/day) and is the city longest expressway, covering 58 km in length and crossing 27 neighborhoods and site 3, Rebouças Tunnel that also has heavy traffic (~190,000 vehicles/day) and is a 2.8 km-long tunnel that connects the northern and southern zones of the city [15-17]. We also evaluated genetic polymorphisms in CYP1A1 (*2B and *4), GSTM1 and GSTT1 and risk of lung cancer in Rebouças tunnel workers (Rio de Janeiro – Brazil).The exposed group was formed by fifteen male workers tunnel Rebouças with age between 25 and 64 years. Peripheral blood samples were collected in tubes containing EDTA during the working day. After collection, the material were cooled and transported to our laboratory. The same procedures were carried out with volunteers in the control group, formed by eleven servants of the State University of Rio de Janeiro, male with age between 30 and 60 years. All procedures were submitted and approved by the National Research Ethics Committee - CONEP (CAAE No . 27402014.6.0000.5259).

Salmonella/micro some assay

The organic extracts [15 -17] were assayed for mutagenicity using the micros uspension version [23] of the Salmonella/ microsome assay [24]. S. enteric serovar Typhimurium TA98 (frame shift strain) and the derivative strains TA98/1.8- DNP6 (O-acetyl transferase-deficient) and TA98NR (nitroreductasedeficient) [9] were used, with and without metabolic activation (S9 mix fraction). Five concentrations of each sample (10, 20, 30, 40, and 50 μg/plate) were tested in triplicate. The samples were pre-incubated for 90 min. All assays were carried out under yellow light and in the presence of negative (5 μL/plate DMSO solvent) and positive (0.5 μg/plate 4-nitroquinoline oxide; CASRN. 56-57-5; Sigma Chemical Company; St. Louis, MO, USA) controls. Plates were incubated in the dark at 37°C for 72 h, after which time revertants were counted. The sample was considered to be positive when the mutagenesis value was at least twice the negative value, and when a significant ANOVA (P <0.05) and a positive dose response rate (P < 0.05) were observed. The results of the different assays were analyzed using the SALANAL program (Salmonella Assay Analysis, version 1.0; Integrated Laboratory Systems; Research Triangle Park, NC, USA). The choice between linear regression and the Bernstein model [25] was made to allow the elimination of data for doses outside the linear portion of the dose-response curve. Positive results were interpreted as presenting significant mutagenicity. Positive responses were expressed as the number revertants per volume of air sampled (rev/m3), i.e., rev/μg multiplied by EOM in μg/m3. In the cytotoxicity test, the solutions containing the sample and he bacterial culture (100-200 cells) were plated on nutrient agar plates and incubated at 37°C for 24 h, and the surviving colonies were counted. The sample was considered to be cytotoxic if the percentage of surviving cells was less than 60% of the negative control at one or more doses [13].

Genetic polymorphism analysis of CYP1A1*2B and CYP1A1*4

The genetic polymorphism analysis for the CYP1A1*2B and CYP1A1*4 were characterized by RFLP after PCR second Cascorbi et al. [26], DNA was extracted by KIT Pure Link® Genomic. All primers were obtained from New England Biolabs (Uniscience, Brazil); PCR reactions were performed with a Biorad Thermal cycler-MyCycler.

For determination of CYP1A1*2B DNA fragment was amplified using 1 unit Taq polymerase, 10 μ moI/liter of primers a 204-bp fragment with primers M2F 5’-CTGTCTCCCTCl’GCITFACAGGAAGC and M2R 5’-TFCCACCCGTTGCAGCAGGATAGCC (reagent concentrations as above; PCR conditions were 35 cycles of 0.5 min at 94° C 0.5 min at 63°C, and 0.5 min at 72°C). The product was digested with BsrDI (New England Biolabs; 0.5 units). CYP1A1*4 could be determined from the same 204-bp fragment but using BsaI (New England Biolabs; 2.5 units). Both cleavage sites were lost in the case of the mutations and were evaluated on Diamond and 1.5% agarosegel. Genetic polymorphism analysis of GSTM1 and GSTT1 genes. The genetic polymorphism analysis for the GSTMland GSTTlgens was determined simultaneously in a single assay using a multiplex PCR approach [27]. DNA was extracted by KIT Pure Link® Genomic. Briefly, isolated DNA (50ng) was amplified in a 25µl reaction mixture containing 0.5 mmol of each of the following GSTM1 primers: 5’ - GAA CTC CCT GAA AAG CTA AAG C-’3 and 5’ GTT GGG CTC AAA TAT ACG GTG G-’3 [15]; and the following GSTT1 primers: 5’-TTCCTTACTGGTCCTCACATCTC-’3 and 5’-TCACCGGATCATGGCCAGCA-’3 in the presence of 0.2 mmol/L dNTPs and 1.5 mmol/L de MgCl2 . The PCR conditions consisted of an initial melting temperature of 95° C (5 min) followed by 35 cycles of melting (94°C, 2 min), annealing (59°C, 1 min) and extension (72°C, 1 min). A final extension step (72°C, 10 min) terminates the process. The PCR products from amplification of GSTT1 and GSTM1 genes were then analyzed electrophoretitally on Diamond and 1.5%agarose gel. The presence or absence of GSTT1 and GSTM1 gens was detected by the presence or absence of a band at 480 bp (corresponding to GSTT1) and a band at 215 bp (corresponding to GSTM1).

RESULTS AND DISCUSSION

Salmonella/microsome assay

The EOM values ranged from 5.54 to 9.66 μg/m3 at site 1, from 5.48 to 7.76μg/m3 at site 2, and from 20.93 to 25.05 μg/ m3 at site 3 in the three months of study, as calculated elsewhere [17]. No cytotoxic effects were detected for any of the samples analyzed. The contribution of nitro compounds to the mutagenic activity of air samples from urban areas is associated with the presence of PAH derivatives. Among these, the mono- and dinitroPAHs associated with oxygenated PAH have been correlated with direct frame shift mutagenic activity (11; 12; 5). The contribution of mono- and di-nitroarenes to direct mutagenic activity was investigated though the Salmonella/microsome assay with strains TA98NR and TA98/1,8- DNP6 , respectively. Nitroarenes are dependent upon this ‘classic’ nitroreductase to express their mutagenicity, as evidenced by their greatly decreased activity in the nitroreductase deficient strain [7]. However, some nitroarenes express all or a major fraction of their activity even in the absence of the ‘classic’ nitroreductase (e.g., 1,8-DNP). The fact that there is residual activity expressed in TA98NR (the microorganism deficient in the ‘classic’ nitroreductase), and the finding of the full expression of the mutagenicity of other chemicals in TA98NR has led to the conclusion that S. entericaserovar Typhimurium may contain additional nitroreductases as well as other specific enzymes. Indeed, it has been possible to construct bacterial strains lacking the enzyme that recognizes 1,8-DNP (e.g., TA98/1,8- DNP6 ) [7]. The lower mutagenic activity in nitroreductasedeficient and O-acetyltransferase-expressing strains, TA98NR and TA98/1,8- DNP6 , compared to the parental strain TA98, indicated the participation of mono- and di-nitroarenes in the total mutagenicity of the extracts. The presence of mononitroarenes was detected at site 2 and site 3. A lower mutagenic response was observed for TA98NR (42% at site 2 and 94-95% at site 3) than was observed for TA98. At site 2 and site 3, a lower mutagenic response was observed for the TA98/1,8-DNP6 strain (28-75% at site 2 and 37-73% at site 3) than for TA98, indicating the presence of di-nitroarenes. The extent of the reduction in the mutagenic response detected at sites 2 and 3 can be attributed to the intense traffic in these areas of the city. Studies performed with TA98NR and TA98/1,8-DNP6 in areas contaminated by vehicular emissions and industrial activity in Rio Grande do Sul State of Brazil showed similar results: a reduction of 10-95% for TA98NR and a reduction of 61-85% for TA98/1,8-DNP6 [12,5]. Similar results were also detected in the industrial city of Cubatão, São Paulo [11]. Meanwhile, an absence of mutagenicity was observed at site 1, which is characteristic of residential areas with a low flow of vehicles. Mutagenic results were detected in the presence of metabolic activation for TA98NR and TA98/1,8- DNP6 for all sites. However, the decrease in revertants after metabolization was only observed in few periods. The effects of the S9 mix preparations on the mutagenicity of nitroarenes in the Salmonella strains revealed a broad spectrum of responses ranging from the absence of mutagenicity to an absolute requirement for mutagenic activation. In some instances, the presence of S9 mix permitted the expression of mutagenicity by nitroarenes even in nitroreductase-deficient microorganisms, indicating the presence of nitroreductase activity in the S9 mix [7]. However, it must be noted that, in general, arylamines exhibit much lower mutagenicity in the presence of S9 mix than do corresponding nitroarenes in the absence of S9 mix. Strains YG1021 and YG1024 are also commonly used in environmental studies [13, 14,17]. The higher mutagenic activity seen in overexpressing strains YG1021 and YG1024 compared to the parental strain TA98 indicates the participation of nitro and amine compounds, respectively. The extracts from sites 1, 2, and 3 were therefore also tested with strains YG1021 and YG1024, and showed the following results: increase in reversion for YG1021 (6-14% at site 1; 2-144% at site 2; 12-281% at site 3), and increase in reversion for YG1024 (3-38% at site 1; 105-155% at site 2; 1-145% at site 3) [17]. Two studies conducted in different parts of Rio Grande do Sul also detected the presence of nitro and amino compounds through the high activity of strains YG1021 (23-264%) and YG1024 (554-1821%) [13,14]. This increase in the percentage of reversal shown by YG1021 and YG1024 is attributed to plasmids pYG216 and pYG219, which increase the sensitivity of these strains to nitro and amino compounds, respectively [6].

Genetic polymorphism analysis

Polymorphism CYP1A1* 2B was detected in all individual’s exposure group. No CYP1A1 polymorphism was detected in control group. Deletions of GSTM1 and GSTT1 genes were detected in 100% of samples from control group. In exposure group, single deletions of GSTM1 or GSTT1 genes were detected in 72.74% (n=11) to 86.37% (n=13), respectively. A number of studies have analyzed a possible association between CYP1A1 polymorphisms with the risk to develop lung cancer [28]. In the present study we analyzed samples from 15 workers Rebouças tunnel (total 50 workers), as genetic polymorphisms in CYP1A1 (*2Band*4), GSTM1 and GSTT1. Our results shows apolymorphism CYP1A1*2B in an individual’s exposure group. The strong relationship between polymorphism CYP1A1*2B and lung cancer was first found in the Japanese population [19,20]. CYP1A1*2B polymorphism was found in Asians at a high allelic frequency (0.22), followed by Latinos (0.16), and Caucasians (0.09), but not in Africans [29, 30]. In our population the CYP1A1*2B polymorphism is present at the same allelic frequency as in Caucasians [29,30]. Studies performed with Brazilian patients, CYP1A1*2B polymorphism also presented an increased risk of developing lung cancer [29,31]. Our results showed deletions of GSTM1 and GSTT1 gens in 100% of samples from control group. In exposure group, deletions of GSTM1 and GSTT1 gens were detected in 72.74% to 86.37%, respectively. In a study by Rossini et al. [32], with volunteer residents of the city of Rio de Janeiro found that 42.1% of the individuals had the GSTM1 null genotype, whereas 25.4% had the GSTT1 null genotype. The prevalence of the deleted GSTM1 genotype in North Americans was 51% and in Egyptians was 44% [33]. The prevalence of the deleted GSTT1 genotype among North Americans was reported by [33]. They reported that the prevalence of the null genotype was highest among African-Americans (21.8%) and Caucasians (20.4%), whereas the prevalence was lowest among MexicanAmericans (9.7%). As CYP1A1 is a phase I enzyme that is involved in carcinogen activation and GSTM1 and GSTT1 is a predominant phase II enzyme for deactivation, they may be complementary in their modulation of cancer risk [30]. CYP1A1 takes part in the activation of PAHs into diol epoxide metabolites in the lung, and GSTM1 and GSTT1 plays an important role in the detoxification of diol epoxide metabolites [30]. Epidemiological studies on Asian population have shown an association between increased risk of lung cancer and the combination of the GSTM1 null genotype and CYP1A1 variants [27].

CONCLUSION

1 - The Salmonella/microsome assay has been used for large, multi-site and/or time serie studies to identify the presence of specific mutagens and classes of mutagens. All the strains used in the present study are sensitive to nitroarene,although strains YG1021 and YG1024 showed the highest rev/ m3 values, thus confirming their enhanced sensitivity. YG1024 also demonstrated sensitivity to nitro and amino compounds. We recommend the use of strains YG1021 and YG1024 in research into environmental contamination by these pollutants.

2 - In our study, the same individual showed CYP1A1*2B polymorphism and deletions of GSTM1 and GSTT1 gens. These results demonstrate that this individual exposed to occupational pollution at Rebouças tunnel, may have intensified metabolizing pollutants such as PAH, and have difficulties in detoxification of metabolites of these pollutants, increasing the risk of lung cancer development.

ACKNOWLEDGEMENTS

Wethank Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for their financial support, andthe Rio de Janeiro citydepartmentsofeducationandtransportation for theirpartnership in thisstudy.

REFERENCES

1. Claxton LD, Matthews PP, Warren SH. The genotoxicity of ambient outdoor air, a review: Salmonella mutagenicity. Mutat Res. 2004; 567: 347-399.

2. DeMarini DM, Brooks LR, Warren SH, Kobayashi T, Gilmour MI, Singh P. Bioassay-directed fractionation and Salmonella mutagenicity of automobile and forklift diesel exhaust particles. Environ Health Perspect. 2004; 112: 814-819.

3. de Aragão Umbuzeiro G, Franco A, Magalhães D, de Castro FJ, Kummrow F, Rech CM, et al. A preliminary characterization of the mutagenicity of atmospheric particulate matter collected during sugar cane harvesting using the Salmonella/ microsomemicrosuspension assay. Environ Mol Mutagen. 2008; 49: 249-255.

4. Menck HR, Casagrande JT and Henderson BE. Industrial air pollution: possible effect on lung cancer. Science 1974; 183: 210-212.

5. Ducatti A, Vargas VM. Mutagenic activity of airborne particulate matter as an indicative measure of atmospheric pollution.Mutat. Res. 2003; 540: 67-77.

6. Watanabe M, Ishidate M Jr, Nohmi T. Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: new derivatives of Salmonella typhimurium tester strains possessing elevated O-acetyltransferase levels. Mutat. Res. 1990; 234: 337-348.

7. Rosenkranz HS, Mermelstein R. Mutagenicity and genotoxicity of nitroarenes. All nitro-containing chemicals were not created equal. Mutat. Res. 1983; 114: 217-267.

8. Wang CY, Lee MS, King CM, Warner PO. Evidence for nitro aromatics as direct-acting mutagens of airborne particulates. Chemosphere 1980; 9: 83-87.

9. Rosenkranz HS, Mermelstein R. The Salmonella Mutagenicity and the E. coli Pol A+/Pol A1- Repair Assays: Evaluation of Relevance to Carcinogenesis. In: The Predictive Value of in vitro Short-term Screening Tests in the Evaluation of Carcinogenicity (Williams GM, Kroes R, Waaijers HW and Van de Poll KW, eds.). Elsevier, Amsterdam. 1980; 5-26.

10. Watanabe M, Ishidate M Jr and Nohmi T. A sensitive method for the detection of mutagenic nitroarenes: construction of nitroreductase overproducing derivatives of Salmonella typhimurium strains TA98 and TA100. Mutat Res. 1989; 216: 211-220. 

11. Sato MI, Valent GU, Coimbrão CA, Coelho MC, Sanchez P, Alonso CD, Martins MT.Mutagenicity of airborne particulate organic material from urban and industrial areas of São Paulo, Brazil. Mutat. Res. 1995; 335; 317-330.

12. Vargas VMF, Horn RC, Guidobono RR, Mittelstaed AB, de Azevedo IG. Mutagenic activity of airborne particulate matter from the urban area of Porto Alegre, Brazil.Genet. Mol Biol. 1998; 21: 247-253.

13. Coronas MV, Pereira TS, Rocha JA, Lemos AT, Fachel JM, Salvadori DM, et al. Genetic biomonitoring of an urban population exposed to mutagenic airborne pollutants. Environ. Int. 2009; 35: 1023-1029.

14. Pereira TS, Gotor GN, Beltrami LS, Nolla CG, Rocha JA, Broto FP, et al. Salmonella mutagenicity assessment of airborne particulate matter collected from urban areas of Rio Grande do Sul State, Brazil, differing in anthropogenic influences and polycyclic aromatic hydrocarbon levels. Mutat. Res. 2010; 702: 78-85

15. Rainho CR, Velho AMA, Aiub CAF, Corrêa SM. Evaluation of Urban Airborne Particulate Matter (PM 2.5) in the City of Rio de Janeiro (Brazil) by Mutagenicity Assays. In: Essays on Environmental Studies (Sarin A, ed.). Athens Institute for Education and Research. Athens. 2012; 1-8.

16. Rainho CR, Velho AMA, Aiub CAF, Corrêa SM, Felzenszwalb, I Health risk prediction induced by polycyclic aromatic hydrocarbons present in respirable urban airbone in Rio de Janeiro (Brazil). Genet. Mol. Res. 2013; 12: 3992-4002.

17. Rainho CR, Corrêa SM, Mazzei JL, Aiub CAF, Felzenszwalb, IGenotoxicity of polycyclic aromatic hydrocarbons and nitro-derived in respirable airborne particulate matter collected from urban areas of Rio de Janeiro (Brazil). BioMed Res. 2013; 1-9.

18. Dresler, CM, Fratelli, C, Babb, J, Everley L, Evanss AA, Clapper ML. Gender differencies in genetic susceptibility for lung cancer. Lung Cancer. 2000; 30: 153-160.

19. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev. 2000; 9: 3-28.

20. Sreeja L, Syamala V, Hariharan S, Madhavan J, Devan SC, Ankathil R. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population. J Hum Genet. 2005; 50: 618-27.

21. Shah PP, Singh AP, Singh M, Mathur N, Pant MC, Mishra BN. et al. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res. 2008; 639: 1-10.

22. Li W, Song LQ, Tan J. Combined effects of CYP1A1 MspI and GSTM1 genetic polymorphisms on risk of lung cancer: an updated metaanalysis. Tumor Biol. 2014; 35: 9281-9290.

23. Kado NY, Guirguis GN, Flessel CP, Chan RC, Chang KI, Weolowski JJ. Mutagenicity of fine (less than 2.5 microns) airborne particles: diurnal variation in community air determined by a Salmonella micro preincubation (microsuspension) procedure. Environ. Mutagen. 1986; 8: 53-66.

24. Maron DM, Ames BN. Revised methods for the Salmonella mutagenicity test. Mutat Res. 1983; 113: 173-215.

25. Bernstein L, Kaldor J, McCann J, Pike MC. An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutat. Res. 1982; 97: 267-281.

26. Cascorbi I, Brockmöller J, Roots I. A C4887A Polymorphism in Exon 7 of Human CYP1A1: Population Frequency, Mutation Linkages, and Impact on Lung Cancer Susceptibility. Cancer Research. 1996; 56: 4965-4969.

27. El-Zein R, Abdel-Rahman SZ, Sankar A, Zwischenberger JB, Au WW. Genetic polymorphism and risk for development of lung cancer, Environmental and Molecular Mutagenesis, 1996; 27: 20-X.

28. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett, 1990; 263: 131-133.

29. Amorim LM, Lotsch PF, Simão Td Tde A, Gallo CV, Pinto LF. Analysis of CYP1A1 exon 7 polymorphisms by PCR-SSCP in a Brazilian population and description of two novel gene variations. Mutat Res. 2004; 547: 35-40.

30.Garte S. The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. Carcinogenesis, 1998; 19: 1329-1332.

31. Hamada GS, Sugimura H, Suzuki I, Nagura K, Kiyokawa E, Iwase T, et al. The heme-binding region polymorphism of cytochrome P4501A1 (Cyp1A1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol Biomarkers Prev. 1995; 4: 63-67.

32. Rossini A, Rapozo DC, Amorim LM, Macedo JM, Medina R, Neto JF, et al. Frequencies of GSTM1, GSTT1, and GSTP1polymorphisms in a Brazilian population. Genet Mol Res. 2002; 30: 233-240.

33. Nelson HH, Wiencke JK, Christiani DC, Cheng TJ, Zuo ZF, Schwartz BS, et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta, Carcinogenesis. 1995; 16: 1243-1245

Received : 08 Aug 2016
Accepted : 01 Nov 2016
Published : 05 Nov 2016
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X